To cut a long story short T, you are misinterpreting the process flow. Been through this process myself through other investments many times before. Its true that TIS must make an initial assessment - however the output of this exercise is to select the correct 'body'. The output isnt to determine the correct classification. TIS is a commercial entity, and is not responsible for standards and regulations. All other things being equal, this would be the FDA if it was a drug submission. The BSI is a standards org. which is responsible for ensuring that the submission conforms to the classification. Thats why it is there, to take the risk out of the process. You could choose to rethink the meaning of "determined" vs "agreed" in the context of the TIS experience, but its irrelevant.
Note; at one point TIS were building a case to begin legal proceeding against the appropriate agency due to a break-down in process; refer independent report.
TIS Price at posting:
32.0¢ Sentiment: Sell Disclosure: Not Held
